- Abstract:
-
BACKGROUND: Intravenous recombinant tissue plasminogen activator (tPA, alteplase) was conditionally licensed for the treatment of acute ischemic stroke (AIS) in Canada on February 17, 1999. As a condition of licensure, the Canadian Activase for Stroke Effectiveness Study (CASES) was established to monitor the use of alteplase for AIS in Canada. The study involves multiple stakeholders. METHODS: CASES is a prospective registry of patients treated with alteplase for AIS. The purposes of this re...
Expand abstract - Publication status:
- Published
- Journal:
- The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
- Volume:
- 28
- Issue:
- 3
- Pages:
- 232-238
- Publication date:
- 2001-08-05
- ISSN:
-
0317-1671
- URN:
-
uuid:f8d47627-fb41-4623-a258-0381a7811414
- Source identifiers:
-
79341
- Local pid:
- pubs:79341
- Copyright date:
- 2001
Journal article
Methodology for the Canadian Activase for Stroke Effectiveness Study (CASES). CASES Investigators.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
If you are the owner of this record, you can report an update to it here: Report update to this record